How Analysts Feel About Codexis, Inc. (CDXS) After Making 52-Week High?

June 8, 2018 - By Winifred Garcia

Codexis, Inc. (NASDAQ:CDXS) Logo

Investors sentiment decreased to 1.34 in Q1 2018. Its down 0.83, from 2.17 in 2017Q4. It fall, as 9 investors sold Codexis, Inc. shares while 20 reduced holdings. 16 funds opened positions while 23 raised stakes. 28.16 million shares or 0.51% more from 28.02 million shares in 2017Q4 were reported.
143,794 were accumulated by Blair William And Il. Tiaa Cref Inv Management Lc reported 87,746 shares. Strs Ohio holds 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS) for 60,200 shares. Eam Invsts Limited Co holds 166,272 shares or 0.3% of its portfolio. Vanguard Grp Incorporated Incorporated invested 0% in Codexis, Inc. (NASDAQ:CDXS). State Bank Of Mellon reported 0% in Codexis, Inc. (NASDAQ:CDXS). Moreover, Financial Architects Inc has 0.02% invested in Codexis, Inc. (NASDAQ:CDXS) for 8,516 shares. Geode Limited Liability Co stated it has 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS). Deutsche Savings Bank Ag holds 0% in Codexis, Inc. (NASDAQ:CDXS) or 61,529 shares. American Intl Grp Inc accumulated 0% or 26,073 shares. Opaleye Management owns 1.70M shares. Vantage Investment Lc holds 0.01% or 3,252 shares in its portfolio. Citadel Advsrs Lc stated it has 0% in Codexis, Inc. (NASDAQ:CDXS). Perkins Mngmt holds 0.27% or 27,000 shares in its portfolio. Retail Bank Of America Corp De has invested 0% in Codexis, Inc. (NASDAQ:CDXS).

Since March 21, 2018, it had 0 insider buys, and 10 insider sales for $2.84 million activity. The insider Smith David V sold $62,213. $124,683 worth of stock was sold by KELLEY BERNARD J on Wednesday, March 21. SANGSTER GORDON had sold 18,736 shares worth $264,307 on Thursday, May 24. Aldridge Michael D. sold 22,000 shares worth $297,865. Cheng Pam P. also sold $549,782 worth of Codexis, Inc. (NASDAQ:CDXS) on Monday, May 21. $259,828 worth of Codexis, Inc. (NASDAQ:CDXS) shares were sold by NICOLS JOHN J.

The stock of Codexis, Inc. (NASDAQ:CDXS) hit a new 52-week high and has $15.85 target or 6.00 % above today’s $14.95 share price. The 6 months bullish chart indicates low risk for the $795.94M company. The 1-year high was reported on Jun, 8 by If the $15.85 price target is reached, the company will be worth $47.76 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 3.55% or $0.55 during the last trading session, reaching $14.95. About 90,369 shares traded. Codexis, Inc. (NASDAQ:CDXS) has risen 215.91% since June 8, 2017 and is uptrending. It has outperformed by 203.34% the S&P500.

Analysts await Codexis, Inc. (NASDAQ:CDXS) to report earnings on August, 8. They expect $-0.13 earnings per share, 0.00 % or $0.00 from last year’s $-0.13 per share. After $-0.10 actual earnings per share reported by Codexis, Inc. for the previous quarter, Wall Street now forecasts 30.00 % negative EPS growth.

Codexis, Inc. (NASDAQ:CDXS) Ratings Coverage

Among 2 analysts covering Codexis (NASDAQ:CDXS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Codexis has $1600 highest and $11.5 lowest target. $13.75’s average target is -8.03% below currents $14.95 stock price. Codexis had 2 analyst reports since March 12, 2018 according to SRatingsIntel. As per Monday, March 12, the company rating was maintained by H.C. Wainwright. The rating was initiated by Stephens with “Buy” on Wednesday, May 16.

More notable recent Codexis, Inc. (NASDAQ:CDXS) news were published by: which released: “Codexis Reports First Quarter 2018 Financial Results” on May 10, 2018, also with their article: “New Research Coverage Highlights WPP, Codexis, Natural Resource Partners LP, Mercer International, Booking, and …” published on June 01, 2018, published: “Codexis’ (CDXS) CEO John Nicols on Q1 2018 Results – Earnings Call Transcript” on May 11, 2018. More interesting news about Codexis, Inc. (NASDAQ:CDXS) were released by: and their article: “Codexis to Present at Three Upcoming Investment Conferences” published on May 29, 2018 as well as‘s news article titled: “Benzinga’s Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO” with publication date: June 01, 2018.

Codexis, Inc. discovers, develops, and sells protein catalysts. The company has market cap of $795.94 million. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening. It currently has negative earnings. The firm also provides protein catalyst screening and protein engineering services.

Codexis, Inc. (NASDAQ:CDXS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: